Drugs News and Research

RSS

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

The United States in recent years has increased healthcare access by broadening Medicaid coverage, but some worry that these Medicaid expansions lead to more abuse of prescription painkillers and thus worsen the opioid epidemic.

28 Sep 2018

Podcast: KHN’s ‘What the Health?’ (Almost) Live from Austin!

President Donald Trump's proposed rule that would make it more difficult for immigrants to gain permanent status if they use government aid programs could have a major impact in Texas, with its large immigrant population.

28 Sep 2018

Eat, toke or vape: Teens not too picky when it comes to pot’s potpourri

There is no doubt that some high school students will try to get high. However, the ways they're doing it might be changing.

28 Sep 2018

New tool provides improved in vivo imaging of atherosclerotic plaque development

Atherosclerosis, involving the buildup of plaque in the arteries and an associated reduction in the flow of blood, is a major feature of cardiovascular diseases.

28 Sep 2018

Australian scientists resolve a key question in ovarian cancer care

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why some patients respond to these drugs, while others do not.

28 Sep 2018

‘Contraception deserts’ likely to widen under new Trump administration policy

When Nikia Jackson needed to be screened for a sexually transmitted disease, she wanted a clinic that was reputable, quick and inexpensive.

28 Sep 2018

Putting oversized health care costs upfront — on T-shirts

If only patients knew how expensive medical procedures are and how wildly prices vary by hospital, they could be smart shoppers and lower the cost of health care for everybody.

28 Sep 2018

Genetic score helps predict future major coronary events, shows study

Coronary artery disease (CAD) is the leading killer of people with type 2 diabetes, and it's not a secret killer.

28 Sep 2018

Broadly neutralizing antibodies offer a new approach to treating HIV infection

A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

28 Sep 2018

UA professor receives NSF grant to study role of stromal cells in breast cancer

Hossein Tavana, Ph.D., an associate professor of biomedical engineering at The University of Akron (UA), has received a single-PI grant in the amount of $328,426 from the National Science Foundation - his third federal grant this year - to study the role of stromal cells in cancer.

28 Sep 2018

Dennis and Mireille Gillings Foundation donates £600,000 for pilot FLIER program

The Academy of Medical Sciences is delighted to announce a pledge of £600,000 from the Dennis and Mireille Gillings Foundation towards a pilot programme to develop two cohorts of innovative new leaders in medical science.

28 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Workers overdose on the job, and employers struggle to respond

Jimmy Sullivan prepared for his job as a bricklayer the same way every morning for years: injecting a shot of heroin before leaving his car.

28 Sep 2018

BHCGC consortium to play key role in NIH's large-scale effort to advance precision medicine

The Baylor College of Medicine Human Genome Sequencing Center today announced participation in the National Institutes of Health All of Us Research Program, a large-scale effort to advance precision medicine.

27 Sep 2018

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the agency's Small Business Innovation Research Program.

27 Sep 2018

Buried in Congress’ opioid bill is protection for personal drug imports

The final version of the massive opioid bill Congress released Wednesday would grant the Food and Drug Administration new powers to crack down on drug imports, but it also includes a provision — nearly killed in the Senate — to shield people who are just trying to buy cheaper, needed prescription medication from other countries.

27 Sep 2018

Daily exercise facilitates elimination of toxic proteins from muscles

A study published in Scientific Reports by researchers at the University of São Paulo in Brazil, in partnership with colleagues in the United States and Norway, shows that the lack of muscle stimulus results in a buildup of inadequately processed proteins in muscle cells and consequently leads to muscle weakness or wasting.

27 Sep 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.

27 Sep 2018

Drugs News and Research

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

Podcast: KHN’s ‘What the Health?’ (Almost) Live from Austin!

Eat, toke or vape: Teens not too picky when it comes to pot’s potpourri

New tool provides improved in vivo imaging of atherosclerotic plaque development

Australian scientists resolve a key question in ovarian cancer care

‘Contraception deserts’ likely to widen under new Trump administration policy

Putting oversized health care costs upfront — on T-shirts

Genetic score helps predict future major coronary events, shows study

Broadly neutralizing antibodies offer a new approach to treating HIV infection

UA professor receives NSF grant to study role of stromal cells in breast cancer

Dennis and Mireille Gillings Foundation donates £600,000 for pilot FLIER program

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Workers overdose on the job, and employers struggle to respond

BHCGC consortium to play key role in NIH's large-scale effort to advance precision medicine

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

Buried in Congress’ opioid bill is protection for personal drug imports

Daily exercise facilitates elimination of toxic proteins from muscles

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News